Pharmaco-proteomicsSerum protein concentration changes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 1026 - 1049 of 1049 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Hydralazine	Approved	REN	5972	increased	Hydralazine results in increased expression of REN protein	1q32.1	2953239 923630
Furosemide	Approved Vet Approved	REN	5972	increased	Furosemide results in increased expression of REN protein	1q32.1	3530574 4028619
Furosemide	Approved Vet Approved	REN	5972	increased	Furosemide results in increased expression of REN protein	1q32.1	3530574 4028619
Ritodrine	Approved Investigational	INS	3630	increased	Ritodrine results in increased expression of INS protein	11p15.5	356601 3883263 9186877
Ritodrine	Approved Investigational	INS	3630	increased	Ritodrine results in increased expression of INS protein	11p15.5	356601 3883263 9186877
Epinephrine	Approved Vet Approved	INS	3630	decreased	Epinephrine results in decreased expression of INS protein	11p15.5	6018752 6314140
Epinephrine	Approved Vet Approved	INS	3630	decreased	Epinephrine results in decreased expression of INS protein	11p15.5	6018752 6314140
Chlorpromazine	Approved Investigational Vet Approved	PRL	5617	increased	Chlorpromazine results in increased expression of PRL protein	6p22.3	718334 996201
Chlorpromazine	Approved Investigational Vet Approved	PRL	5617	increased	Chlorpromazine results in increased expression of PRL protein	6p22.3	718334 996201
Spironolactone	Approved	AGT	183	increased	Spironolactone results in increased expression of AGT protein modified form	1q42.2	7357812 9595286
Spironolactone	Approved	AGT	183	increased	Spironolactone results in increased expression of AGT protein modified form	1q42.2	7357812 9595286
Heparin	Approved Investigational	SERPINC1	462	decreased	Heparin results in decreased expression of SERPINC1 protein	1q25.1	73932 8122184
Hydrocortisone	Approved Vet Approved	INS	3630	increased	Hydrocortisone results in increased expression of INS protein	11p15.5	7473517 7792821 7917157
Hydrocortisone	Approved Vet Approved	INS	3630	increased	Hydrocortisone results in increased expression of INS protein	11p15.5	7473517 7792821 7917157
Octreotide	Approved Investigational	INS	3630	decreased	Octreotide results in decreased expression of INS protein	11p15.5	7493436 7917157
Methotrexate	Approved	COL3A1	1281	increased	Methotrexate results in increased expression of COL3A1 protein	2q32.2	7577576 8667468
Beclomethasone dipropionate	Approved Investigational	BGLAP	632	decreased	Beclomethasone results in decreased expression of BGLAP protein	1q22	7746775 9232087 9544892
Beclomethasone dipropionate	Approved Investigational	BGLAP	632	decreased	Beclomethasone results in decreased expression of BGLAP protein	1q22	7746775 9232087 9544892
Lansoprazole	Approved Investigational	GAST	2520	increased	Lansoprazole results in increased expression of GAST protein	17q21.2	7750667 8792694
Lansoprazole	Approved Investigational	GAST	2520	increased	Lansoprazole results in increased expression of GAST protein	17q21.2	7750667 8792694
Bezafibrate	Approved Investigational	APOA2	336	increased	Bezafibrate results in increased expression of APOA2 protein	1q23.3	7893284 8017468
Ifosfamide	Approved	B2M	567	increased	Ifosfamide results in increased expression of B2M protein	15q21.1	8625085 9261752
Ifosfamide	Approved	B2M	567	increased	Ifosfamide results in increased expression of B2M protein	15q21.1	8625085 9261752
Verapamil	Approved	PRL	5617	increased	Verapamil results in increased expression of PRL protein	6p22.3	8845563 8977754

Displaying entries 1026 - 1049 of 1049 in total

Pharmaco-proteomicsSerum protein concentration changes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability